Skip to content

Clinical trials

Phase 3 Neoplasm Metastasis trials in Turkey (Türkiye)

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 3 Country / region: Turkey (Türkiye) Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20081
20092
20101
20122
20133
20145
20151
20161
20171
20181
20193
20201
20217
20226
20232
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Active, not recruiting13
Recruiting6
Terminated4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca12
Eli Lilly and Company7
Novartis Pharmaceuticals4
AbbVie3
Pfizer3
Sanofi2
Amgen1
Astellas Pharma Europe Ltd.1
Ataturk University1
BeiGene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis46
Breast Neoplasms13
Neoplasms11
Carcinoma, Non-Small-Cell Lung8
Melanoma4
Prostatic Neoplasms4
Breast Diseases3
Carcinoma3
Neoplasms by Site3
Skin Diseases3

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.